Community/ Public / Population Health

Ozone-depleting inhalers to be phased out

On April 13, the U.S. Food and Drug Administration announced that seven metered-dose inhalers used for asthma and chronic obstructive pulmonary disease will gradually be removed from the market because they contain ozone-depleting cholorofluorocarbons (CFCs). Find more details and the schedule for removal at

Related Articles:

Leave a Reply

You have to agree to the comment policy.